Bernard Zovighian is Chief Executive Officer and Director of Edwards Lifesciences Corp (EW). The company reported total compensation of $17,454,255 for fiscal year 2025.
| Salary | $1,192,500 |
|---|---|
| Bonus | $0 |
| Stock awards | $7,167,024 |
| Option awards | $6,499,109 |
| Non-equity incentive plan | $2,406,537 |
| Pension and non-qualified deferred compensation | $0 |
| All other compensation | $189,085 |
| Total | $17,454,255 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure Edwards Lifesciences Corp filed March 26, 2026, accession 0001099800-26-000015.
| Fiscal year | Role | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|---|
| FY2025 | Chief Executive Officer and Director | $1,192,500 | $0 | $7,167,024 | $6,499,109 | $2,406,537 | $0 | $189,085 | $17,454,255 |
| FY2024 | Chief Executive Officer | $1,133,846 | $0 | $6,147,250 | $5,748,762 | $1,451,588 | $0 | $98,028 | $14,579,474 |
| FY2023 | Chief Executive Officer | $972,814 | $0 | $5,099,085 | $5,500,679 | $1,234,207 | $0 | $62,235 | $12,869,020 |
Totals as disclosed in each year's own compensation disclosure for Edwards Lifesciences Corp.
| Peer-group chief executive median | $17,129,140 |
|---|---|
| Difference from that median | $325,115 |
| Percentile within the disclosed peer group | 53rd |
| Peers with a disclosed figure | 17 |
Medians and percentiles are computed across the peer group Edwards Lifesciences Corp discloses in its own compensation disclosure.
| Named executive officer | Role | FY2025 total |
|---|---|---|
| Bernard Zovighian this page | Chief Executive Officer and Director | $17,454,255 |
| Scott Ullem | Corporate Vice President, Chief Financial Officer | $6,050,554 |
| Larry Wood | Former Corporate Vice President and Group President, Transcatheter Aortic Valve Replacement and Surgical Structural Heart | $4,854,339 |
| Daveen Chopra | Corporate Vice President, Transcatheter Mitral and Tricuspid Therapies | $4,695,742 |
| Donald Bobo | Corporate Vice President, Strategy & Corporate Development | $4,223,365 |
| Annette Brüls | Corporate Vice President, EMEACLA | $3,732,107 |
The company's named executive officers for fiscal year 2025, and what it reported for each. See the full Edwards Lifesciences Corp compensation brief.
Bernard Zovighian's compensation sits inside Edwards Lifesciences Corp's full executive and board picture — the peer group, pay against peers, incentive design and the board itself.